课题基金 / 基金详情

项目摘要

项目成果

Sarah Hartz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Severe mental illness and substance use disorder frequently co-occur. Individuals suffering from schizophrenia—a common, persistent, and severe mental illness—have much higher rates of heavy alcohol use and smoking than the general population. Similarly, individuals with substance use disorder often suffer from other mental illnesses. For example, 22% of individuals with alcohol use disorder have another mental illness, compared to 11% of individuals without alcohol use disorder. Despite the prevalence of comorbidity, it is not known whether shared genetic factors contribute to schizophrenia and substance use disorders. In this study, we use existing genome-wide association study (GWAS) data and state-of-the-art statistical methodology to evaluate whether schizophrenia shares genetic factors with alcohol use disorder or nicotine dependence. Specifically, in aim 1 we will evaluate whether genetic factors that contribute to schizophrenia also contribute to alcohol use disorder and to nicotine dependence. Then, in aim 2, we will evaluate whether genetic factors that contribute to either alcohol use disorder or nicotine dependence also contribute to schizophrenia. This novel proposal is significant because it will lead to improved understanding of comorbidity of schizophrenia with alcohol use disorder and with nicotine dependence at a genetic level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies
  • 批准号:
    10557822
  • 项目类别:
  • 资助金额:
    $70.61万
  • 财政年份:
    2020
  • 负责人:
    Sarah Hartz
  • 依托单位:
海外基金